1 completed, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow BioLab 612 LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis CBLB612, Placebo - Breast Cancer | Phase 2 | Completed | BioLab 612 LLC | 23 | 2015-12-01 | 2016-07-20 |
| Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer CBLB502, Placebo - Colorectal Cancer | Phase 2 | Unknown | BioLab 612 LLC | 40 | 2015-11-01 | 2017-02-09 |
Breast Neoplasms (1) · Colorectal Neoplasms (1) · Neutropenia (1)
CBLB502 (1)
Russia (1)
Aleksei G. Manikhas, MD PhD (1) · Dmitrii A. Krasnozhon, MD PhD (1) · Natalia V. Fadeeva, MD PhD (1) · Nikolay V. Kislov, MD PhD (1) · Roman S. Ponomarev, MD PhD (1) · Ruslan M. Paltuev, MD PhD (1) · Sergei A. Tiuliandin, MD PhD (1) · Sergei I. Achkasov, MD PhD (1) · Sergei V. Odintcov, MD PhD (1)